Tuesday's Twitter panic shows just how unprepared the market is to make a wide exodus out of bonds and into stocks. More
Should I Buy Exxon Mobil? 3 Pros, 3 Cons
Like most energy majors, Exxon Mobil is susceptible to commodity prices, but the company is about as well-positioned and smartly led as it gets. More
7 Insurance Stocks to Buy Now
This week, seven Insurance stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy"). More
5 Overlooked MLPs With Hefty Yields
As investor interest in MLPs has swelled, yields have diminished. If you look off the beaten path, though, you can still find huge payouts. More
6 Biotechnology Stocks to Buy Now
Six Biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More
Diagnostic Lab Stocks Are Bleeding Out
Given poor quarterly earnings and the uncertainty about how Obamacare will affect healthcare, investors should keep these stocks on quarantine. More
